Private company
Medicus Sciences Acquisition Corp.
Blank check company in the Cayman Islands1
In its 2022 annual report the company says: “We are a blank check company incorporated in November 2020 as a Cayman Islands exempted company incorporated for the purpose of effecting an initial business combination.Since our initial public offering, we have focused our search for an initial business combination on businesses that may provide significant opportunities for attractive investor returns.”28 It is headquartered in New York, New York.1
Last updated Oct 21, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare Medicus Sciences Acquisition Corp. with another company
Corporate structure
Medicus Sciences Acquisition Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Medicus Sciences Acquisition Corp.
- First Trust Capital Management L.P. Filed SC 13G/A on Medicus Sciences Acquisition Corp., latest Feb 12, 2024 (2 filings since Feb 14, 2023)
- Saba Capital Management, L.P. Filed SC 13G/A on Medicus Sciences Acquisition Corp., latest Feb 8, 2024 (2 filings since Feb 14, 2022)
- D. E. SHAW & CO, L.P. Filed SC 13G/A on Medicus Sciences Acquisition Corp., latest Feb 14, 2023 (2 filings since Jan 18, 2022)
- GLAZER CAPITAL, LLC Filed SC 13G on Medicus Sciences Acquisition Corp., latest Feb 14, 2023
- Third Point LLC Filed SC 13G/A on Medicus Sciences Acquisition Corp., latest Feb 10, 2023 (2 filings since Feb 14, 2022)
- Cowen Financial Products LLC Filed SC 13G/A on Medicus Sciences Acquisition Corp., latest Jan 24, 2023 (2 filings since Mar 11, 2022)
- HealthCor Management, L.P. Filed SC 13G/A on Medicus Sciences Acquisition Corp., latest Feb 14, 2022
- Medicus Sciences Holdings LLC Filed SC 13G on Medicus Sciences Acquisition Corp., latest Feb 14, 2022
- Medicus Sciences Acquisition Corp. New York, New York
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Medicus Sciences Acquisition Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led Medicus Sciences Acquisition Corp., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
- Chief executive officerMichael Castor Feb 12, 2021 to Feb 12, 20217
- ChairJacob Gottlieb Feb 12, 2021 to Feb 12, 20218
- Chief financial officerJudah Drillick Feb 12, 2021 to Feb 12, 20219
Board members and other officers (5)
- Chief Business OfficerEric Cheng Feb 12, 2021 to Feb 12, 202110
- Board memberChristopher Kaster Feb 12, 2021 to Feb 12, 202111
- Board memberKenneth Berkovitz Feb 12, 2021 to Feb 12, 202112
- Board memberMichael Castor Feb 12, 2021 to Feb 12, 20217
- Board memberRoss Levine Feb 12, 2021 to Feb 12, 202113
Timeline
- Feb 13, 20238-K Other events14
- Jan 18, 20238-K Listing notice or transfer15
- Mar 28, 20228-K Executive or director change16
- Feb 15, 20228-K Regulation FD disclosure17
- Feb 8, 20228-K Regulation FD disclosure18
- Dec 6, 20218-K Earlier financial statements no longer reliable19
- Feb 12, 2021New chief executive Michael Castor becomes CEO7
Filings
26 filings to the SEC since October 2021: 1 annual reports, 5 quarterly reports, 6 major events, 13 large holders, 1 other. The latest 20:
- Feb 12, 2024SC 13G/A EDGAR
- Feb 8, 2024SC 13G/A EDGAR
- Feb 27, 202315-12G EDGAR
- Feb 14, 2023SC 13G MSAC 13G EDGAR
- Feb 14, 2023SC 13G/A EDGAR
- Feb 14, 2023SC 13G EDGAR
- Feb 13, 20238-K EDGAR
- Feb 10, 2023SC 13G/A SCHEDULE 13G/A (AMENDMENT NO. 1) EDGAR
- Jan 24, 2023SC 13G/A COWEN FINANCIAL PRODUCTS LLC EDGAR
- Jan 18, 20238-K EDGAR
- Nov 14, 202210-Q EDGAR
- Aug 11, 202210-Q EDGAR
- May 12, 202210-Q EDGAR
- Mar 31, 202210-K FORM 10K EDGAR
- Mar 28, 20228-K EDGAR
- Mar 11, 2022SC 13G COWEN FINANCIAL PRODUCTS LLC EDGAR
- Feb 15, 20228-K EDGAR
- Feb 14, 2022SC 13G EDGAR
- Feb 14, 2022SC 13G/A EDGAR
- Feb 14, 2022SC 13G/A EDGAR
The 26 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- First Trust Capital Management L.P.SC 13G/A, 2 filings Feb 14, 2023 to Feb 12, 202420
- Saba Capital Management, L.P.SC 13G/A, 2 filings Feb 14, 2022 to Feb 8, 202421
- D. E. SHAW & CO, L.P.SC 13G/A, 2 filings Jan 18, 2022 to Feb 14, 202322
- GLAZER CAPITAL, LLCSC 13G, 1 filing Feb 14, 202323
- Third Point LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 10, 202324
- Cowen Financial Products LLCSC 13G/A, 2 filings Mar 11, 2022 to Jan 24, 202325
- HealthCor Management, L.P.SC 13G/A, 1 filing Feb 14, 202226
- Medicus Sciences Holdings LLCSC 13G, 1 filing Feb 14, 202227
SEC filer profile
How Medicus Sciences Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARMedicus Sciences Acquisition Corp.1
- CIK0001836517
- Filer status<br>emerging growth company1
- Incorporated inCayman Islands1
- Fiscal year endsDecember 311
- Industry code (SIC)6770 Blank Checks1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business address152 West 57Th Street, Floor 20, New York, NY 100191
- Phone21225984001
- Public float$89.7M as of Jun 30, 20212
- On EDGAR sinceDec 23, 20201
- Filings57 in all: 8-K (9), SC 13G (9), 3 (8), SC 13G/A (7), 10-Q (6), CORRESP (3), 10-K (2), 25-NSE (2)1
All 18 form types
S-1/A (2), 10-Q/A (1), 15-12G (1), 424B4 (1), 8-A12B (1), CERT (1), EFFECT (1), NT 10-Q (1), S-1 (1), UPLOAD (1)
- Latest filingsAnnual report (10-K) Mar 31, 2022
Quarterly report (10-Q) Nov 14, 2022
Latest 8-K (8-K) Feb 13, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARJacob Gottlieb, Chair
- 9
- 10SEC EDGAREric Cheng, Chief Business Officer
- 11SEC EDGARChristopher Kaster, Board member
- 12SEC EDGARKenneth Berkovitz, Board member
- 13SEC EDGARRoss Levine, Board member
- 14SEC EDGAROther events
- 15SEC EDGARListing notice or transfer
- 16SEC EDGARExecutive or director change
- 17SEC EDGARRegulation FD disclosure
- 18SEC EDGARRegulation FD disclosure
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28